InvestorsHub Logo
Followers 33
Posts 2856
Boards Moderated 1
Alias Born 10/24/2015

Re: jondoeuk post# 78

Friday, 10/04/2019 4:11:16 PM

Friday, October 04, 2019 4:11:16 PM

Post# of 262
Technically, these are GSK's, but I still think the data will be important.

(P224) Case studies of sarcoma and MRCLS following treatment with NY-ESO-1 TCR T Cells (GSK3377794): correlates of predictable response characteristics

(P358) Phase 1 trial of NY-ESO-1-specific adoptive T-cell therapy with GSK3377794 in patients with advanced synovial sarcoma

(P359) Tracking and profiling of NY-ESO-1 TCR-transgenic T cells upon adoptive transfer in patients with NY-ESO-1-expressing solid tumors: in vivo differentiation associated with response
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADAP News